Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 2:34 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 601–624 of 3,925 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Advanced Chronic Liver Disease, Surgery--Complications
Interventions: Not listed
Lead sponsor: Azienda Ospedaliera Universitaria Integrata Verona; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Hypertension
Interventions: Stress Management Training; Behavioral
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 55 Years to 100 Years
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Type 2 Diabetes, Hypertension
Interventions: Exercise training for 6 months; Behavioral
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 40 Years to 65 Years
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hypertension
Interventions: Morning meal challenge, Evening meal challenge; Other
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Preeclampsia
Interventions: Not listed
Lead sponsor: Carl Weiner, MD; Other
Eligibility: 16 Years to 45 Years · Female only
Enrollment: 431 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Esophageal Varices
Interventions: PillCam Eso; Device
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years and older
Enrollment: 318 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 3
States / cities: Scottsdale, Arizona • Plymouth, Minnesota • Portland, Oregon

Conditions: Hypertension
Interventions: Grocery Vouchers; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 50 Years and older
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 2
States / cities: New Orleans, Louisiana

Conditions: Hypertension
Interventions: Losartan Potassium; Drug
Lead sponsor: Roxane Laboratories; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004
U.S. locations: 1
States / cities: Springfield, Missouri

Conditions: Hypertension
Interventions: Walking (behavior); Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 25 Years to 59 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2004
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Refractory Ascites, Hepatic Hydrothorax, Hepatic Encephalopathy, Cirrhosis
Interventions: Oral glutamine challenge, Psychometric Tests; Other
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 75 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Preeclampsia, Proteinuria, Hypertension, Pregnancy
Interventions: urine collection; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 14 Years to 50 Years · Female only
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Uncontrolled Hypertension
Interventions: BAROSTIM NEO System and Medical Management; Device
Lead sponsor: CVRx, Inc.; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2025
U.S. locations: 11
States / cities: Phoenix, Arizona • Los Angeles, California • Washington D.C., District of Columbia + 8 more

Conditions: Glaucoma, Ocular Hypertension
Interventions: ibuprofen, latanoprost, brimonidine, Ibuprofen, brimonidine, latanoprost, Ibuprofen; Drug
Lead sponsor: Philadelphia Eye Associates; Other
Eligibility: 21 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 3
States / cities: Willingboro, New Jersey • Philadelphia, Pennsylvania

Conditions: Ocular Hypertension, Primary Open Angle Glaucoma
Interventions: AKB-9778 Ophthalmic Solution, Placebo Ophthalmic Solution; Drug
Lead sponsor: Aerpio Therapeutics; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 91 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 2
States / cities: Austin, Texas • Dallas, Texas

Conditions: Hypertension
Interventions: ATHENA-CDS-HTN plus Guideline Link, Guideline Link Only; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Enrollment: 103 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 7
States / cities: Palo Alto, California • Newington, Connecticut • West Haven, Connecticut + 4 more

Conditions: Glaucoma, Primary Open Angle
Interventions: oxygen inhalation, Adaptive optics imaging; Other · Device
Lead sponsor: Food and Drug Administration (FDA); Federal
Eligibility: 21 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2028
U.S. locations: 1
States / cities: Silver Spring, Maryland

Conditions: Hypertension
Interventions: Controls-ususal care, Cases-remote patient monitoring prescribed; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 110 Years
Enrollment: 1,440 participants
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Prehypertension, Hypertension
Interventions: Nebivolol, Metoprolol, Placebo, Bradykinin, Saline, Vitamin C; Drug · Other
Lead sponsor: University of Colorado, Boulder; Other
Eligibility: 45 Years to 65 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Chronic Kidney Diseases, Hypertension
Interventions: KBP-5074 0.25 mg tablet, KBP-5074 0.5 mg tablet; Drug
Lead sponsor: KBP Biosciences; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: Princeton, New Jersey • Morrisville, North Carolina

Conditions: Idiopathic Pulmonary Fibrosis (IPF), Sarcoidosis Lung, Pulmonary Hypertension, Usual Interstitial Pneumonia
Interventions: Not listed
Lead sponsor: Cosmos Rx, Inc; Industry
Eligibility: 21 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Hypertension, Obstructive Sleep Apnea
Interventions: Not listed
Lead sponsor: NYU Langone Health; Other
Eligibility: 10 Years to 17 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Mineola, New York

Conditions: Pulmonary Arterial Hypertension
Interventions: Iloprost Inhalation Solution (Ventavis); Drug
Lead sponsor: Actelion; Industry
Eligibility: 3 Years to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 2
States / cities: Denver, Colorado • New York, New York

Conditions: Hypertension, Type 2 Diabetes, Metabolic Syndrome, Smoking, High Cholesterol, PreDiabetes, Prehypertension
Interventions: Project WHADE: A Partner-Based Physical Activity Program for Women; Behavioral
Lead sponsor: Rowan University; Other
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Glassboro, New Jersey

Conditions: Esophageal and Gastric Varices
Interventions: Esophageal Capsule Endoscopy, Upper Gastrointestinal Endoscopy; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Non-invasive Methods and Surgical Risk Stratification in Cirrhotics Undergoing Elective Extrahepatic Surgery

Mechanisms of the Relaxation Response in Elderly Hypertensives

Exercise Training in Type 2 Diabetes and Hypertension

Chronobiology of Meal Timing: Effects on Vascular and Renal Function

A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk

"Evaluation of the PillCam™ESO Capsule in the Detection of Esophageal Varices

Food Is Medicine: Makin' Healthy Groceries

Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted Conditions

Walking Intervention in African American Adults With Newly Diagnosed Hypertension

Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)

Comparison of Catheterized and Clean Catch Urine Specimens for Protein/Creatinine Ratio in Preeclampsia Evaluation

BAROSTIM NEO Hypertension Pivotal Trial

Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AKB-9778 Ophthalmic Solution

VISN Collaborative for Improving Hypertension Management With ATHENA-HTN

Adaptive Optics Retinal Imaging

Hypertension Management Using Remote Patient Monitoring

Nebivolol and Endothelial Regulation of Fibrinolysis (NERF)

Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease

A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension

Hypertension and Sleep Disordered Breathing in Pediatrics

Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension

Project WHADE: A Partner-Based Physical Activity Program for Women

Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy